Navigation Links
A prognosis for GE and Abbott Diagnostics

such as its pharmaceuticals and devices - are marketed mostly through physicians and direct-to-consumer channels.

GE has a significant marketing advantage and experience when it comes to big-box purchases. Moreover, the GE commercial finance arm also facilitates the ability to purchase these big boxes through leasing or other arrangements. The same marketing strength can also be applied t......

Full article >>>
'"/>

Source:wistechnology.com By Ogan Gurel 02/05/07


Page: 1 2 3 4 5 6 7

Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. Wisconsin court halts Abbotts sale of genotyping products
3. Wisconsin court affirms damages in Innogenetics, Abbott patent case
4. Abbott Labs campus in Kenosha could send ripples through local biotech
5. Abbott Executive Jim Tyree Takes IBIO Helm
6. Promega Announces Agreement with Abbott
7. Roche Diagnostics Corporation
8. Roche Diagnostics Corporation
9. BioDiagnostics is first seed-testing lab to gain new accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: prognosis for and Abbott Diagnostics

(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... joint venture with G-treeBNT (ReGenTree LLC) has retained ... trial for the orphan disorder, neurotrophic keratopathy (NK), ... eye syndrome (DES) in the U.S.  Both trials ... this year.  Each of these eye disorders was ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., ... of therapeutic antibodies, today announced the advancement ... program into IND-enabling studies. The Company,s anti-IL-36R ... treatment for generalized pustular psoriasis (GPP), an ... medical need. ANB019 is wholly owned within AnaptysBio,s ...
(Date:4/16/2015)... Switzerland , April 16, ... part of Debiopharm Group ™ , a Swiss-based ... target unmet medical needs as well as ... on the investigational compounds Debio 1143 (SMAC mimetic) ... presented at the 2015 Annual meeting of ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
... March 25 How long is the menopausal,transition? New ... and their,health care providers -- think. Clinicians often face ... and how,long these symptoms will last., To meet ... Family,Practice and OBG Management have published two supplements dealing ...
... 25 Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ) today ... Tuesday, April 1st, 2008 at 10:00am EDT to review,2007 ... Company., To access the conference call, please dial ... conference call is,7767549. Please dial in 5 to 10 ...
... CITY, China, March 25 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, ... one of the leading plasma-based pharmaceutical companies in ... one of its R&D,projects, "High-concentration Human Hepatitis B ... China., The National Torch Plan was organized ...
Cached Biology Technology:Hot Information for Physicians Treating Vasomotor Symptoms During the Menopausal Transition 2Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call 2Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call 3China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 2China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 3
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... are urgently needed in resource-limited countries. A ... Microbiology colloquium, "Bringing the Lab to the Patient: ... the challenges inherent in bringing new medical devices ... where they are needed most. Point-of-care diagnostics (POCTs) ...
... helped open a new door of possibility in the high-stakes ... an international team, the scientists including Stanford Woods Institute ... found a way to create future ocean conditions in a ... the device can mimic the composition of the future ocean ...
... world dolomite is quite common. More than 90 percent of ... first described scientifically in the 18th century. But who would ... not fully understood, although geologists are aware of large deposits ... years. The process of recent primary dolomite formation is restricted ...
Cached Biology News:Report addresses challenges in implementing new diagnostic tests where they are needed most 2Stanford researchers help predict the oceans of the future with a mini-lab 2How does dolomite form? 2
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
...
Biology Products: